Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Industry Leaders to Meet in Taiwan for Clinical Outsourcing and Collaboration Opportunities

Published: Monday, October 15, 2012
Last Updated: Monday, October 15, 2012
Bookmark and Share
Focused clinical trials meeting platform in Taipei, bringing together industry stakeholders, regulators and academics.

The number of trials conducted in Taiwan has reached 2671, ranking in 3rd in Asia, after China and Korea. The market was valued at $114.9 million in 2010 and expected to continue growing to $209.7 million in 2015 at a CAGR of 13%. However, challenges on how to further carve out Taiwan in the competitive regional trials scene still remain, while more discussion on how the region could create extensive collaboration to continue contributing to the globalisation of trials is also needed.

On signing a memorandum of understanding with local Chang Gung Memorial Hospital on 5 October 2012, pharma giant GlaxoSmithKline commented that the collaboration on the clinical R&D center will focus on diseases which oftentimes break outs in Asia and contribute to more consistent trials on Asian patients with products that have been well-tested on humans of other ethnicities.

Taiwan Trials – 26-27 February 2013 - is the ONLY focused clinical trial conference in Taiwan, bringing together pharma, biotechs, CROs, regulators and hospitals as well as technology and solution providers from Taiwan and the rest of the world.

This conference was developed with the support of our Advisory Board of the top industry experts namely Dr James Garner, Vice President and General Manager, Takeda Global Research and Development Center (Asia), Singapore; Dr Ko-Chung Lin, Founder and CEO, PharmaEssentia, Taiwan; Dr Lars Nelleman, Vice President, Clinical Development Center, Asia Pacific, Lundbeck A/S, Singapore; Dr James Wang, Head of Research & Development, TaiMed Biologics Inc., Taiwan and Dr Ming-Qiang Zhang, Vice President and Head of Asia Pacific R&D, Merck Sharp & Dohme, China.

We are glad to have on board, Efficient Pharma Management Corp, as the Exhibitor, together with the support of BiotechEast as the Marketing Partner, and the endorsement of various associations namely Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA), Sino-American Pharmaceutical Professionals Association – Greater Philadelphia (SAPA-GP) and Pan-Asian Clinical Research Association (PACRA).

Featured speakers will include
- Dr James Garner, Vice President and General Manager, Takeda Global Research and Development Center (Asia), Singapore
- Dr Lars Nelleman, Vice President, Clinical Development Center, Asia Pacific, Lundbeck A/S, Singapore
- Dr Rosalind Lu, Asia-Pacific Regional Head for Roche Product Development Global Operation Country Clinical Operation, Roche Pharmaceuticals, Taiwan
- Dr Chin-Fu Hsiao, Director of the Division of Clinical Trials Statistics, National Health Research Institutes, Taiwan
- Pilar de la Rocha Mur, Global Monitoring Operations Head of the Asia Pacific and South Africa Region, Norvatis, Singapore
- Min-Hsiung Kao, Clinical Operation Director, Taiwan Liposome Company Ltd, Taiwan
- Dr Hui-Ling Shieh, Medical Director, Yung Shin Pharm Ind. Co., Taiwan
- Gregory Liu, Head of Medical Department, Oncology Business Unit, TTY Biopharm, Taiwan and Clinical Research Director, TOT Biopharm, China
- Dr Hung Jen Lai, Medical Director, Merck Sharp and Dohme, Taiwan
- Dr Ko-Chung Lin, Founder and Chief Executive Officer, PharmaEssentia, Taiwan
- Catherine Yi-San Lee, Executive Director, Area Head of Clinical Trials Support and Compliance Asia, Pfizer Inc.

WHO: Taiwan Trials 2013
WHEN: 26-27 February 2013
WHERE: Taipei, Taiwan
Early Special Rate closing 31 October 2012


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Structure of Crucial Enzyme Identified
Researchers at UTSW have determined the atomic structure of an enzyme that plays an essential role in cell division and better treatment of cancer.
New Immunotherapy Trial for Type 1 Diabetes
The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy’s Hospital in London.
Recruitment of First Patient in Clinical Study
Company has announced recruitment of first patient in clinical study assessing Visco-ease with Beatson Cancer Centre for the treatment of RIX.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!